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shows that there are more than 400 plant species showing 
hypoglycemic activity.[2]
Stephania  hernandifolia  (Willd.)  Walp.  (Family- 
Menispermaceae) is a slender twining shrub found in hilly 
areas, above 900 meters (approximately) from the sea level. 
The plant is useful in the treatment of fever, diarrhea, 
diabetes, urinary disease, dyspepsia, depilatory.[3,4] The 
main objectives of this study are to assess the antidiabetic 
and antioxidant potential of ethanol and aqueous 
extracts of the powdered corm of Stephania hernandifolia 
INTRODUCTION
The use of herbal medicines for the treatment of diabetes 
mellitus has gained importance throughout the world. 
The World Health Organization has also recommended 
and encouraged this practice, especially in countries 
where access to the conventional treatment of diabetes 
is not adequate. There is an increased demand for using 
natural products with antidiabetic activity, on account 
of the side effects associated with the use of insulin 
and oral hypoglycemic agents.[1] The available literature 
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ABSTRACT
Stephania hernandifolia (Menispermaceae) is a medicinal plant, used by herbalists for treating various diseases, 
one of which is diabetes mellitus, in Darjeeling. However, its antidiabetic activity has not been scientifically 
investigated so far. The aim of this study, therefore, is to investigate the antidiabetic and antioxidant potential 
of the powdered corm of Stephania hernandifolia. This was tested in normal and Streptozotocin (STZ)-induced 
diabetic rats, using oral administration of ethanol and an aqueous extract (400 mg/kg body weight) of Stephania 
hernandifolia corm. After the oral administration of water and ethanol extracts at doses of 400 mg/kg body weight, 
blood glucose levels were monitored at specific intervals and it was found that they were significant lowered. 
Glibenclamide was used as a standard drug at a dose of 0.25 mg/kg. The experimental data revealed that both 
extracts has significant antihyperglycemic and antioxidant activity in Streptozotocin-induced rats compared to 
the standard drug. The antioxidant activity in vitro was measured by means of the 1, 1-diphenyl-2-picrylhydrazyl 
(DPPH) and Superoxide-free radical scavenging assay. Ascorbic acid, a natural antioxidant, was used as a 
control. The extracts of ethanol and aqueous were strongly scavenged DPPH radicals, with IC50 being 265.33 
and 217.90 µg/ml, respectively. Although the extracts of ethanol and aqueous were moderately scavenged, the 
superoxide radical were with IC50 values of 526.87 and 440.89 µg/ml. The study revealed that the ethanolic 
extract exhibited more significant antidiabetic and antioxidant activity then the aqueous extract.
Key words: Antidiabetic, antioxidant, glibenclamide, lipid profile, Stephania hernandifolia, Streptozotocin
DOI: 10.4103/0975-1483.66803256   J Young Pharm Vol 2 / No 3
Sharma, et al. J Young Pharm. 2010;2(3): 255-260
in control of blood glucose levels and effectiveness on 
various biochemical parameters, namely, total cholesterol, 
triglycerides (TGL), high density lipoprotein (HDL), 
low density lipoprotein, (LDL), and very low density 
lipoprotein, (VLDL), with antioxidant studies. 
MATERIALS AND METHODS
Plant material
The plant Stephania hernandifolia (Willd.) Walp. has been 
collected from Darjeeling district of West Bengal, India, 
during summer. The species for the proposed study was 
identified as Stephania hernandifolia (Willd.) Walp. by Dr. 
P. Jayaraman, Botanist, Plant Anatomy Research Centre 
(PARC), Chennai. 
Preparation of  Stephania hernandifolia corm 
ethanolic and aqueous extracts
The powder of the corm (300 g) of Stephania hernandifolia 
(Willd.) Walp., was packed well in the Soxhlet apparatus and 
extracted with ethanol and distilled water separately, until 
the completion of the extraction. The extract was filtered 
while hot, and the resultant extract was distilled in vacuum 
under reduced pressure in order to remove the solvent 
completely, and later dried in a desiccator.[5]
Animals
Male Wistar albino rats having a weight of 170 – 220 g were 
kept in quarantine for 10 days under standard husbandry 
conditions (27.3o, Relative humidity 65 ± 10%) for 12 
hours in dark and light cycle, respectively, and were given 
standard food and water ad libitum. The study was permitted 
by the Institution Animal Ethical Committee with Reg. No. 
CPCSEA/265.
Acute toxicity testing
Acute toxicity testing was performed for both ethanol and 
aqueous extracts following the Organization for Economic 
Cooperation and Development (OECD) guidelines-420, 
fixed dose procedure, where a fixed dose level of extracts 
starting from 50, 100, 200, 500, 1000, increasing up to 2000 
mg/kg body weight was given, and signs and symptoms of 
toxicity were observed for the next 48 hours. No toxicity 
or death was observed in the experimental rats.[6,7]
Oral glucose tolerance test (OGTT)
The oral glucose tolerance test[8] was performed in overnight 
fasted (18 hours) normal rats. The rats were divided into 
three groups (n = 6) and were administered drinking water, 
Stephania hernandifolia ethanol extract (400 mg/kg), and 
aqueous extracts (400 mg/kg), respectively. Glucose (2 g/
kg) was fed 30 minutes prior to the administration of the 
extracts. Blood was withdrawn from the retro-orbital sinus 
after 30, 60, and 120 minutes of extract administration, and 
the plasma obtained after centrifugation at 3000 rpm was 
estimated for fasting plasma glucose levels using a glucose 
oxidase–peroxidase glucose estimation kit.
Induction of non-insulin dependent diabetes mellitus 
(NIDDM)
Non-insulin dependent diabetes mellitus was induced[9,10] 
in overnight fasted adult Wistar strain albino male 
rats weighing 170 – 220 g by a single intraperitoneal 
injection of 60 mg/kg Streptozotocin, 15 minutes after 
i.p. administration of 120 mg/kg of nicotinamide. 
Streptozotocin (STZ) was dissolved in a citrate buffer 
(pH 4.5) and nicotinamide was dissolved in normal saline. 
Hyperglycemia was confirmed by the elevated glucose 
levels in plasma, determined at 72 hours and then on day 
7, after injection. The threshold value of fasting plasma 
glucose to diagnose diabetes was taken as > 126 mg/
dl. Only those rats that were found to have permanent 
NIDDM were used for the study. 
Experimental design
The animals were segregated into five groups of six rats 
each. The extract was administered for 12 days. Group 
I served as normal control rats, administered drinking 
water daily for 12 days; Group II had diabetic control rats, 
administered drinking water daily for 12 days; Group III 
diabetic rats were administered ethanol extract (400 mg/
kg); Group IV diabetic rats were administered aqueous 
extract (400 mg/kg); and Group V diabetic rats were 
administered standard drug glibenclamide (0.25 mg/kg) 
for 12 days. 
The fasting glucose levels were determined on days 1, 5, 
and 12 of extract administration. During the experimental 
period, the rats were weighed daily and the mean change 
in body weight was calculated.
Estimation of biochemical parameters 
The biochemical parameters were determined on day 12 
after the animals were sacrificed by cervical dislocation. 
Total cholesterol, triglycerides (TGL), high-density 
lipoprotein (HDL), low-density lipoprotein (LDL), and J Young Pharm Vol 2 / No 3  257
very low-density lipoprotein (VLDL), were determined by 
the glucose oxidase method, using an auto-analyzer.[11,12]
Determination of hydrogen-donating activity 
The hydrogen donating activity was quantified in the 
presence of a stable DPPH radical on the basis of the 
Blois method. Briefly, to a methanolic solution of DPPH 
(100 m M, 2.95 ml), 0.05 ml of both extracts dissolved in 
methanol were added at different concentrations (200 – 
1000 µg/ml). The reaction mixture was shaken and after 
30 minutes at room temperature, the absorbance values 
were measured at 518 nm and converted into percentage 
of antioxidant activity (% AA). Ascorbic acid was used as 
the standard.[13,14] The degree of discoloration indicated the 
scavenging efficacy of the extract, which was calculated by 
the following equation:
% AA = 100 – {[(Abssample – Absblank) x 100] / AbsDPPH}
Determination of the superoxide scavenging activity 
Superoxide scavenging was carried out by using alkaline 
DMSO. Solid potassium superoxide was allowed to stand 
in contact with dry DMSO for at least 24 hours and the 
solution was filtered immediately before use. Filtrate (200 
ml) was added to 2.8 ml of an aqueous solution containing 
nitroblue tetrazolium (56 m M), EDTA (10 mM), and 
potassium phosphate buffer (10 mM, pH 7.4). Sample 
extract (1 ml) in various concentrations (200 – 1000 µg/
ml) in water was added and the absorbance was recorded at 
560 nm against a control in which pure DMSO was added 
instead of alkaline DMSO.[15,16]
Statistical analysis
The results are expressed as mean ± SEM of six independent 
experiments. Statistical significance between the groups 
was evaluated by one-way analysis of variance (ANOVA) 
followed by Dunet’s test. A P < 0.05 value was considered 
as statistically significant. For antioxidant activity, values 
representing the concentrations of investigated extracts 
that cause 50% of neutralization / inhibition (IC50) were 
determined by linear regression analysis. 
RESULTS
The effects of ethanol and aqueous extracts of Stephania 
hernandifolia on the plasma glucose level are shown in 
Table 1. In rats treated with both the extracts, there was 
a significant reduction in plasma glucose level, while in 
normal control rats the plasma glucose level increased. 
Induction of diabetes in experimental rats was confirmed 
by the presence of a high fasting plasma glucose level. The 
effect of both extracts of Stephania hernandifolia, on fasting 
plasma glucose level of normal and Streptozotocin-induced 
rats are shown in Table 2. 
The difference between the experimental and control rats 
in lowering the fasting plasma glucose levels was statistically 
significant (P < 0.05) in diabetic rats. From Table 2 it was 
seen that the decrease in glucose level with both extracts 
was less when compared to that with the standard drug. 
Significant differences were also observed in the level of 
total cholesterol, HDL, triglycerides, VLDL, and LDL in 
diabetic rats [Table 3]. During the study, the body weight 
Table 1: Effect of ethanol and aqueous extracts of Stephania hernandifolia on oral glucose tolerance test
Group Plasma glucose concentration (mg/dl)
30 min 60 min 90 min
Normal control 72.66 ± 1.75 97.17 ± 2.28 95.2 ± 1.94
Normal + EESH (400 mg/kg) 64.68 ± 2.13* 82.52 ± 2.19* 70.1 ± 1.18*
Normal + AESH (400 mg/kg) 69.12 ± 1.37 87.92 ± 1.78* 72.55 ± 1.14*
Ethanol extract of Stephania hernandifolia (EESH), Aqueous extract of Stephania hernandifolia (AESH), Values are expressed as mean ± SEM (Number of animals, n = 6); 
*Significantly different from the normal control at P < 0.05
Table 2: Effect of ethanol and aqueous extracts of Stephania hernandifolia on fasting plasma glucose level in rats
Group Fasting plasma glucose concentration (mg/dl)
Day 1 Day 5 Day 12
Normal control 75.91 ± 1.65 77.01 ± 1.88 75.61 ± 1.41
Diabetic control (Streptozotocin) 189.17 ± 2.35* 192.3 ± 1.41* 202.4 ± 2.40*
Diabetic + EESH (400 mg/kg) 188.53 ± 1.99* 108.23 ± 2.78* 90.51 ± 2.97*
Diabetic + AESH (400 mg/kg) 191.38 ± 2.16* 122.6 ± 2.91* 99.47 ± 3.01
Diabetic + Standard Glibenclamide (0.25 mg/kg) 192.11 ± 2.68* 98.17 ± 1.73* 80.9 ± 1.84*
Ethanol extract of Stephania hernandifolia (EESH), Aqueous extract of Stephania hernandifolia (AESH), Values are expressed as mean ± SEM (Number of animals, n = 6); 
*Significantly different from the normal control at P < 0.05
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of diabetic animals that were treated with extracts and 
the standard drug, throughout the twelve days was also 
followed and no significant change was observed [Table 4].
The ethanol extract possessed a higher antioxidant activity 
compared to that of the aqueous extract in DPPH [IC  50: 
EESH versus AESH; 265.33 versus 217.90, Table 5, Figures 
1, 2] as also superoxide scavenging capacity [IC  50: EESH 
versus AESH; 526.87 versus 440.89, Table 6, Figures 3, 4].
DISCUSSION
The fundamental mechanism underlying hyperglycemia 
in diabetes mellitus involves over-production and 
decreased utilization of glucose by the tissues. In our 
study, the difference observed between the initial and final 
fasting plasma glucose levels of different groups under 
investigation, revealed a significant elevation in blood 
glucose in the diabetic control group as compared to normal 
animals, at the end of the twelve-day experimental period. 
When ethanol and aqueous extracts of Stephania hernandifolia 
were administered to glucose-loaded normal rats, fasted for 
18 hours, a decrease in plasma glucose level was observed 
after 30 minutes. Both the extracts reduced plasma glucose 
level to normal at 90 minutes [Table 1]. During the study 
it was found that both extracts significantly controlled the 
blood glucose level in Streptozotocin-induced diabetic rats. 
The ethanol and aqueous extracts induced a significant 
reduction in blood glucose level in STZ-induced-diabetic 
rats as compared to the diabetic control group [Table 2]. 
However, the ethanol extract showed more significant 
antidiabetic activity as compared to the aqueous extract. 
The possible mechanism by which Stephania hernandifolia 
Table 3: Determination of biochemical parameters after treatment with ethanol and aqueous extracts of Stephania 
hernandifolia and Glibenclamide
Group Total cholesterol 
(mg/dl)
HDL (mg/dl) Triglycerides 
(mg/dl)
VLDL (mg/dl) LDL (mg/dl)
Normal control 80.0 ± 3.01 49.73 2.55 81.47 ± 2.61 29.99 ± 2.71 39.11 ± 3.73
Diabetic control (Streptozotocin) 149.3±4.04* 46.72 1.99 177.8 ± 2.91* 64.08 3.74* 155.2±4.45*
Diabetic + EESH (400 mg/kg) 69.44 ± 2.84 43.63 2.81 98.5 ± 3.38* 23.72 ± 2.40 55.4 ± 3.96*
Diabetic + AESH (400 mg/kg) 74.85 ± 4.32 44.61 3.37 103.61 4.52* 25.02 ± 3.45 82.84±2.81*
Diabetic + Standard Glibenclamide (0.25 mg/kg) 59.23±3.12* 43.46 3.79 88.16 ± 3.52* 28.62 ± 3.23 32.96 3.66*
Ethanol extract of Stephania hernandifolia (EESH), Aqueous extract of Stephania hernandifolia (AESH), Values are expressed as mean ± SEM (Number of animals, n = 6); 
*Significantly different from the normal control at P < 0.05
Table 4: Effect of ethanol and aqueous extracts of Stephania hernandifolia on changes in body weight in rats
Group Day 1 Day 5 Day 12
Normal control 176.72±2.23 182.28±1.40 173.54±3.71
Diabetic control (Streptozotocin) 190.47±3.71 185.81±2.87 168.16±2.47
Diabetic + EESH (400 mg/kg) 188.29±2.56 185.46±3.04 179.35±1.12
Diabetic + AESH (400 mg/kg) 184.31±1.93 186.73±4.11 177.82±3.54
Diabetic + Standard Glibenclamide (0.25 mg/kg) 191.5 ± 4.12 188.35±2.74 180.81±2.87
Ethanol extract of Stephania hernandifolia (EESH), Aqueous extract of Stephania hernandifolia (AESH), Values are expressed as mean ± SEM (Number of animals, n = 6)
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Figure 1: IC50 values of ethanol extract of free radical scavenging 
capacity, from the data, were calculated by regression analysis
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Figure 2: IC50 values of aqueous extract of free radical scavenging 
capacity, from the data, were calculated by regression analysis
brought about its hypoglycemic action in diabetic rats 
might be by potentiating the insulin effect of plasma, by 
increasing either the pancreatic secretion of insulin from 
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the existing beta cells or by its release from the bound 
form. A marked increase in serum triglycerides and 
cholesterol was observed in untreated diabetic rats. Under 
normal circumstances insulin activated enzyme lipoprotein 
lipase and hydrolyses triglycerides. Insulin deficiency 
resulted in failure to activate the enzymes thereby causing 
hypertriglyceridemia. A significant control of the levels of 
serum lipids in diabetic rats treated with both the extracts 
could be directly attributed to improvements in insulin 
levels upon Stephania hernandifolia therapy. Elevation of 
plasma lipid concentration in diabetes is well-documented. 
In insulin-deficient diabetics, the plasma-free fatty acid 
concentration is elevated as a result of increased free fatty 
acid outflow from the fat depots, where the balance of the 
free fatty acid esterification–triglyceride lipolysis cycle is 
displaced in favor of lipolysis. Induction of diabetes with 
STZ is associated with characteristic loss of body weight, 
which is due to increased muscle wasting in diabetes.[17] 
Diabetic rats treated with the extracts showed an increase 
in body weight when compared with the diabetic control, 
which may be due to its protective effect in controlling 
muscle wasting, that is, reversal of gluconeogenesis. 
Abnormalities in lipoproteins are very common in both 
NIDDM and IDDM. Although lipoprotein alterations 
appear to be an intrinsic part of these disorders, such 
alterations are also induced by diabetes-associated 
complications such as obesity and renal disease.[18] The 
total cholesterol, triglyceride levels, VLDL, and LDL 
were observed to be elevated in diabetics, but reduced 
by both extracts as well as glibenclamide, showing their 
beneficial effects. In the present study, HDL levels 
remained unchanged in diabetics compared to the other 
groups [Table 3]. These results suggest that the beneficial 
effects of the natural extract in improving the imbalance 
in lipoprotein metabolism are also comparable to those 
of glibenclamide.
In recent times, there has been a considerable debate 
regarding the extent to which increased oxidative 
stress contributes toward the development of diabetic 
complications. The role of antioxidant compounds in both 
Table 5: Free radical scavenging capacity of ethanol 
and aqueous extracts of Stephania hernandifolia
Concentration DPPH Scavenging %
(µg/ml) Ethanol 
Extract
Aqueous 
Extract
Ascorbic Acid
200 42.65 ± 0.58 44.11 ± 1.68 94.35 ± 1.25
400 59.58 ± 1.14 62.41 ± 1.75 -
600 77.45 ± 1.85 80.52 ± 1.96 -
800 85.32 ± 2.45 88.56 ± 1.37 -
1000 91.15 ± 1.32 93.12 ± 0.85 -
IC50 265.33 217.90 -
Values are means ± SEM of six determinations
Table 6: Super oxide scavenging capacity of ethanol and aqueous extracts of Stephania hernandifolia
Concentration (µg/ml) Superoxide Scavenging %
Ethanol Extract Aqueous Extract Ascorbic Acid
200 29.23 ± 0.47 33.75 ± 1.25 89.41 ± 1.52
400 41.39 ± 1.08 47.23 ± 2.36 -
600 55.85 ± 0.96 60.25 ± 2.41 -
800 67.45 ± 1.48 75.45 ± 2.16 -
1000 79.12 ± 1.56 86.32 ± 2.04 -
IC50 526.87 440.89 -
Values are means ± SEM of six determinations
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Figure 3: IC50 values of ethanol extract of superoxide scavenging 
capacity, from the data, were calculated by regression analysis
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Figure 4: IC50 values of aqueous extract of superoxide scavenging 
capacity, from the data, were calculated by regression analysis
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the protection and therapy of diabetes mellitus was also 
emphasized in previous scientific researches. Hyperglycemia 
results in the generation of free radicals that can exhaust 
antioxidant defenses thus leading to the disruption of 
cellular functions, oxidative damage to membranes, and 
enhanced susceptibility to lipid peroxidation. Flavonoids 
are one of the most numerous and widespread groups of 
phenolics in plants. Some of them, due to their phenolic 
structure, are known to be involved in the healing process 
of free radical-mediated diseases, including diabetes.[19] In 
our study, the ethanol and aqueous extracts were found 
to have a strong antioxidant activity. This may be due 
to the presence of phenols and flavonoids, which may 
have a major role in reducing oxidative stress associated 
with diabetes. Thus the significant antidiabetic activity of 
ethanol and aqueous extracts of Stephania hernandifolia in 
our study, may be attributed to the presence of flavonoids 
in the plant. 
The present study has indicated the fact that the plant 
Stephania hernandifolia (Willd.) Walp., has antidiabetic 
constituents and production of a safe antidiabetic drug is 
very much possible from the corm.
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